BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 154 filers reported holding BIODELIVERY SCIENCES INTL IN in Q3 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $203,000 | -14.3% | 65,344 | -0.4% | 0.00% | – |
| Q3 2021 | $237,000 | +1.3% | 65,590 | +0.4% | 0.00% | – |
| Q2 2021 | $234,000 | -7.5% | 65,359 | +1.2% | 0.00% | – |
| Q1 2021 | $253,000 | -6.6% | 64,600 | 0.0% | 0.00% | – |
| Q4 2020 | $271,000 | +12.4% | 64,600 | 0.0% | 0.00% | – |
| Q3 2020 | $241,000 | -14.5% | 64,600 | 0.0% | 0.00% | – |
| Q2 2020 | $282,000 | +15.1% | 64,600 | 0.0% | 0.00% | – |
| Q1 2020 | $245,000 | -40.0% | 64,600 | 0.0% | 0.00% | – |
| Q4 2019 | $408,000 | +13.3% | 64,600 | -24.4% | 0.00% | – |
| Q3 2019 | $360,000 | -7.5% | 85,500 | +2.2% | 0.00% | – |
| Q2 2019 | $389,000 | +186.0% | 83,700 | +98.3% | 0.00% | – |
| Q1 2016 | $136,000 | -93.8% | 42,200 | -90.8% | 0.00% | -100.0% |
| Q4 2015 | $2,206,000 | -13.9% | 460,608 | 0.0% | 0.00% | -25.0% |
| Q3 2015 | $2,561,000 | -30.8% | 460,608 | -0.9% | 0.00% | -20.0% |
| Q2 2015 | $3,701,000 | +24.3% | 464,912 | +64.0% | 0.01% | +25.0% |
| Q1 2015 | $2,977,000 | – | 283,514 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,575,000 | $6,615,000 | 4.38% |
| 1492 Capital Management LLC | 790,863 | $3,322,000 | 1.91% |
| Rubric Capital Management LP | 3,516,124 | $14,768,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $40,026,000 | 0.79% |
| Zebra Capital Management LLC | 144,241 | $606,000 | 0.77% |
| KNOTT DAVID M | 370,230 | $1,555,000 | 0.70% |
| Nantahala Capital Management | 5,123,671 | $21,519,000 | 0.67% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,593,893 | $15,094,000 | 0.66% |
| EMC Capital Management | 98,933 | $416,000 | 0.32% |
| ALGERT GLOBAL LLC | 175,170 | $736,000 | 0.21% |